Executive SummaryGerard Gilbert to VP-commercial development, with responsibility for licensing, new business development and planning. He joined the company in 1986 from Roche; Robert Lippert to director-licensing & international development.
You may also be interested in...
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.
CAR-T therapies are groundbreaking in clinical terms, but have hit barriers in uptake. Can BMS’s challenger go one better than Yescarta and Kymriah?